CSL (MEX:CSL N) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CSL N CSL Ltd MEX:CSL N
78 GF Score
Price MXN2,081.30
GF Value MXN4,856.14
! 7 Warning Signs
View Full Analysis

What is CSL Net Loan?

Net Loan only applies to banks and insurance companies.

MEX:CSL N
78GF Score
CSL Ltd MEX:CSL N
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CSL (MEX:CSL N) Overvalued in 2026?

Based on GuruFocus' analysis, CSL stock appears to be undervalued. The current stock price of MXN2,081.30 is trading 57.1% below its estimated GF Value™ of MXN4,856.14.

Key valuation signals for MEX:CSL N:

  • Net Loan:
  • GF Value™: MXN4,856.14 vs. price of MXN2,081.30 (57.1% below fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the MEX:CSL N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSL Business Description

Address 655 Elizabeth Street, Melbourne, VIC, AUS, 3000
CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
78GF Score

Get the complete analysis for MEX:CSL N

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,081.30
Price
MXN4,856.14
GF Value